Progression free survival (PFS) benefits of immuno-oncology agents (IOs) and implications for market cost-sharing inefficiencies. Meeting Abstract (Web of Science)

cited authors

  • Ashraf, Syed Muhammad Mushtaq; Pandita, Shruti; Alimpertis, Emmanouil; Khan, Talal; Verghese, Cherian

publication date

  • May 20, 2019

webpage

published in

category

volume

  • 37

issue

  • 15